Furfine, Eric,Dix, Daniel,Graham, Kenneth S.,Frye, Kelly
申请号：
AU2007261536
公开号：
AU2007261536B2
申请日:
2007.06.14
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has the amino acid sequence shown in SEQ ID NO:4.
